Perlecan haploinsufficiency due to heterozygous mutation in the candidate modifier gene Hspg2 reduces the viability of mgΔlpn mice (Figures 1E,F), thereby suggesting that concurrence of the Hspg2 and Fbn1 variants may compromise the long term survival of patients with MFS. The gene discussed is FBN1; the disease is Marfan syndrome.